Steven Valiquette
Stock Analyst at Mizuho
(3.13)
# 1,147
Out of 4,876 analysts
109
Total ratings
66.67%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Outperform | $280 → $295 | $280.09 | +5.32% | 3 | Jun 2, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $60.40 | -0.66% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $185.65 | +31.97% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $722.00 | -4.43% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $164.71 | -8.93% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $15.84 | +13.67% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $74.63 | +9.88% | 2 | Mar 3, 2025 | |
| LFMD LifeMD | Initiates: Neutral | $7 | $13.10 | -46.56% | 1 | Dec 4, 2024 | |
| HQY HealthEquity | Initiates: Outperform | $126 | $104.86 | +20.16% | 1 | Dec 4, 2024 | |
| HSIC Henry Schein | Initiates: Neutral | $75 | $73.11 | +2.59% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.75 | +81.82% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $20 | $19.63 | +1.91% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $8.30 | +68.67% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $178.99 | -20.66% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $63.15 | -12.90% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $152.50 | -39.67% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $303.82 | +85.97% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $68.14 | +46.76% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.51 | +210.42% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $291.28 | +37.32% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $53.59 | +99.68% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $30.41 | -44.10% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $6.96 | +72.54% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $121.54 | -21.01% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $177.06 | -32.23% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $379.25 | -66.51% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $239.89 | +49.24% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $11.39 | +426.78% | 3 | Apr 3, 2019 |
Veeva Systems
Jun 2, 2025
Maintains: Outperform
Price Target: $280 → $295
Current: $280.09
Upside: +5.32%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $60.40
Upside: -0.66%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $185.65
Upside: +31.97%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $722.00
Upside: -4.43%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $164.71
Upside: -8.93%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $15.84
Upside: +13.67%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $74.63
Upside: +9.88%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $13.10
Upside: -46.56%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $104.86
Upside: +20.16%
Henry Schein
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $73.11
Upside: +2.59%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.75
Upside: +81.82%
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $19.63
Upside: +1.91%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $8.30
Upside: +68.67%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $178.99
Upside: -20.66%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $63.15
Upside: -12.90%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $152.50
Upside: -39.67%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $303.82
Upside: +85.97%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $68.14
Upside: +46.76%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.51
Upside: +210.42%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $291.28
Upside: +37.32%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $53.59
Upside: +99.68%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $30.41
Upside: -44.10%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $6.96
Upside: +72.54%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $121.54
Upside: -21.01%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $177.06
Upside: -32.23%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $379.25
Upside: -66.51%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $239.89
Upside: +49.24%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $11.39
Upside: +426.78%